cagrisema semaglutide cagrilintide combination trial Coadministered and in Adults with Overweight or Obesity Cagrilintide–semaglutide (CagriSema) as an add-on

For most Canadians starting GLP-1 therapy today, Semaglutide hits the sweet spot of proven efficacy, established long-term safety, demonstrated cardiovascular protection, and reasonable tolerability

Individualized treatment should consider efficacy, safety, and patient-specific factors (e.g., drug interactions, comorbidities) (Alsheikh-Ali et al

While they do not directly target the disc the way injectable peptides might, hydrolyzed collagen peptides provide the raw amino acids, particularly glycine and proline, that the body needs for connective tissue synthesis

Let's break down exactly what the data shows, where the side effect risks shift, and who should actually consider making the move

Over 30 years of preclinical research

Those with Fitzpatrick skin tone 5 typically see results within four to six months